Form CORRESP - Correspondence:
SEC Accession No. 0001437749-23-025385
Filing Date
2023-09-07
Accepted
2023-09-07 15:31:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5520
  Complete submission text file 0001437749-23-025385.txt   6533
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2835 In Vitro & In Vivo Diagnostic Substances